1 / 5

Research by Dr Amarjit Mishra – Disease-modifying therapies for Allergic Asthma Targeting Metabolic Sensors

One of the most brilliant researchers of all timeu00a0Dr. Amarjit Mishra, Ex-Assistant Professor of Auburn Universityu00a0has been working on identifying the various metabolic sensors that can be used for therapeutic purposes for asthma patients.<br>

amarjitmishraasstprof
Download Presentation

Research by Dr Amarjit Mishra – Disease-modifying therapies for Allergic Asthma Targeting Metabolic Sensors

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. RESEARCH BY DR AMARJIT MISHRA – DISEASE-MODIFYING THERAPIES FOR ALLERGIC ASTHMA: TARGETING METABOLIC SENSORS By targeting the inflammatory response through various disease-modifying therapies, asthma management strategies can be developed to control symptoms and reduce the risk of asthma exacerbations. One of the most brilliant researchers of all time Dr. Amarjit Mishra, Ex-Assistant Professor of Auburn University has been working on identifying the various metabolic sensors that can be used for therapeutic purposes for asthma patients.

  2. VARIOUS METABOLIC SENSORS Some disease-modifying therapies have been identified for allergic asthma. Firstly, allergen immunotherapy, also known as allergy shots, is a disease-modifying therapy for allergic asthma. It involves regular injections of small amounts of the allergen over a period of several months or years.

  3. Scientists such as Dr. Amarjit Mishra, Ex-Assistant Professor, Auburn University, have found that disease-modifying medicines for allergic asthma attempt to change the disease’s underlying processes and enhance asthma management. Further research is being conducted to discover the many metabolic sensors that might be targeted to build effective medicines for treating asthma,

  4. Changes in energy metabolism in asthmatic lungs, for example, resulting in activation of the leukotriene synthesis pathway or higher consumption of L-arginine as a substrate, are frequently addressed by adopting various treatment tactics to restore equilibrium. Various phenotypes of asthma are controlled differently through diverse metabolic pathways, with glycolysis mediators such as HIF1a and PKM2 controlling not just DC and T-cell effector activity in type 2 high asthma,

  5. SOME OF THE MOST NOTABLE METABOLIC In conclusion, targeting metabolic sensors is a new area of study in the field of allergic asthma, as identified by prominent scientists including Dr. Mishra, Yuanyuan Wu, Wei Li, and Yifan Hu. According to various experimental studies conducted in animal models of allergic asthma, activation of AMPK, SIRT1, and PPAR-γ has shown promise in decreasing inflammation and improving lung function. Source:- https://resistancephl.com/research-by-dr-amarjit-mishra-disease-modifying-therapies-for-allergic-asthma-targeting-metabolic-sensors/

More Related